期刊文献+

脂蛋白脂酶基因HindⅢ多态性与2型糖尿病合并冠心病和胰岛素抵抗的相关性研究 被引量:8

HindⅢ polymorphism of lipoprotein lipase gene correlates with type 2 diabetes mellitus complicated coronary heart disease and insulin resistance
在线阅读 下载PDF
导出
摘要 目的:探讨脂蛋白脂酶基因HindⅢ多态性与2型糖尿病(DM)合并冠心病及胰岛素抵抗的关系。方法:随机选择2型DM患者203例,其中合并冠心病(CHD)76例(A组),无CHD的2型DM患者127例(B组),健康对照93例(C组),相互间无血缘关系;采用PCR-RFLP方法检测所有受试者脂蛋白脂酶(LPL)基因HindⅢ限制性酶切位点多态性,测量其血脂、血糖水平、DM组空腹胰岛素水平并进行体格检查,用HOMA模型公式计算胰岛素抵抗指数(HOMA-IR)和胰岛细胞敏感指数(HOMA-IS)。结果:DM组及对照组3种基因型均检出,为纯合子H+H+型、H-H-型,杂合子H+H-型;两组间基因型和等位基因分布频率差异无统计学意义(P>0.05);A组H+H+型56例,非H+H+型(包括H+H-型、H-H-型)20例,与B组患者差异有统计学意义(P<0.01);A组患者LPL基因H+H+型HOMA-IR明显高于非H+H+型者(P<0.01),且高于B组H+H+型和非H+H+型者(P<0.01)。同时,A组血TG升高、HDL降低,与B组、健康对照相比,差异具有统计学意义(P<0.01)。结论:高TG、低HDL是DM合并CHD的危险因素,LPL基因H+H+型携带者是DM发生CHD的易感亚群,LPL基因H+H+型与DM合并CHD患者胰岛素抵抗相关。 Objective: To explore the relationship between lipoprotein lipase(LPL) gene HindⅢ polymorphism and type 2 mellitus (DM) diabetes complicated coronary heart disease(CHD) accompanied with insulin resistance. Methods: Two hundred and three type 2 DM patients, included 76 with CHD(group A) and 127 without CHD (group B), and 93 healthy control were selected randomly. All had no blood relationship. The LPL gene Hind Ⅲpolymorphism was studied by polymerase chain reaction (PCR) and restriction fragment length polymorphisms (RFLP). The levels of serum lipid, blood glucose, indexes of height, weight, circumference of waist and abdomen, body mass index (BMI) and waist -to-hip ratio (WHR) were measured in all subjects. At the same time, the fasting insulin (FINS) was tested and the indexes of insulin resistense (IR) and insulin sensitivity(IS) were calculated by HOMA formula. Results: Three genotypes including homozygote H+H+ (+/+) were detected in this experiment homozygote H-H- (-/-) and homozygote H+H- (+/-).Homozygote H+H+ was the major allele in both diabetic group and control group. There was no significant difference in frequencies of genotypes or alleles between diabetic patients and controls; H+H+ genotype were detected 56 cases in group A which was significant higher than that in group B. HOMA-IR of H+H+ genotype in group A was higher than that of the other genotypes, and it was higher than that of H+H+ genotype and the other genotypes in group B. The level of serum triglyceride(TG)in group A was higher than that in group B. At the same time the level of serum highdensity lipoprotein (HDL) in group A was lower than that in group B. Conclusions: The high level of serum TG and the low level of HDL are the risk factors of DM with CHD. Type 2 DM patients carrying H+H+ genotype are the susceptible subcrowd of CHD. LPL gene H+H+ genotype is associated with IR in DM with CHD.
出处 《山东大学学报(医学版)》 CAS 北大核心 2005年第4期301-305,共5页 Journal of Shandong University:Health Sciences
关键词 糖尿病 非胰岛素依赖型 冠状动脉疾病 胰岛素抵抗 脂蛋白脂酶 HindⅢ多态性 Type 2 diabetes mellitus Coronary heart disease Insulin resistance Lipoprotein lipase HindⅢ polymorphism
  • 相关文献

参考文献10

  • 1项佑贵,倪培华,陈铭生.脂蛋白脂酶基因HindⅢ多态性与冠心病及血脂的关系[J].临床检验杂志,2002,20(1):42-44. 被引量:5
  • 2Haffner SM, D-Agostino R, Mykknenl L, et al. Insulin sensitivity in subjects with type 2 diabetes. Relationship to cardiovascular risk factors: the insulin resistance atheroclerosis study[J]. Diabetes Care, 1999, 22(4): 62.
  • 3Ahn YI, Kamboh RF, Hamman SA, et al. Two DNA polymorphisms in the lipoprotein lipase gene and their associations with factors related to cardiovascular disease[J]. J Lipid Res, 1993, 34(3): 421-428.
  • 4Chamberlain JC, Thorn JA,Oka K, et al. DNA polymorphisms at the lipoprotein lipase gene: associations in normal and hypertriglyceridaemic subjects [J].Atherosclerosis. 1989, 79:85-91.
  • 5冯霞,周新,刘芳,郑芳,陈谦,彭建宏,于连.冠心病患者脂蛋白脂酶基因HindⅢ多态性及与血脂的关系[J].武汉大学学报(医学版),2004,25(2):209-212. 被引量:3
  • 6Chan LY, Lan CW, Mak YT, et al. Genotype-phenotype studies of six novel LPL mutations in Chinese patients with hypertriglyceridemia genetic basis of hypertriglyceridemia [J]. Hum Mutat, 2002, 20:232-233.
  • 7Colwell JA.Multifactorial aspects of treatment of the type 2 diabetic patients [J]. Metabolism, 1997, 46(Supple 1):1-4.
  • 8Lasko M, Lehto S, Penttila I, et al. Lipids and lipoprotein predicting coronary heart disease mortality and morbidity in patients with ono-insulin-dependent diabetes [J].Circulation, 1993, 88(4Ptl): 1 421-1 430.
  • 9Heizmann C, Kirchgener T, Kwiterovich PO, et al. DNA polymorphism haplotypes of the lipoprotein lipase gene:possible association with high density lipoprotein levels[J]. Human Genet, 1991, 86(6): 578-584.
  • 10Wen-Jane L, Wayne HS, Chii-Yun Jeng, et al. Association between lipoprotein lipase gene polymorphisms and insulin resistance in coronary heart disease [J].Chin Med J, 2000, 63(7): 563-572.

二级参考文献8

  • 1裴兰,王士雯,叶平.冠心病与脂蛋白脂酶基因多态性关联的研究[J].中华医学杂志,1996,76(7):547-548. 被引量:3
  • 2Rachel M F,Steve EH,Philippa JT. Common variation in the lipoprotein lipase gene:effects on plasm lipids and risk of atherosclerosis.Atherosclerosis,1997,135:145
  • 3shagisultanova EI,Mustafima OE,Tuktarova IA,et al. HindⅢ polymorphism of lipoprotein lipase gene and risk of myocardial infarction. Mol Gen Mikrobiol Virusol,2001,18
  • 4Ahn Y I,Lamboh MI,Hamman RF,et al. Two DNA polymorphisms in the lipoprotein lipase gene and their associations with factors related to cardiovascular disease. J L Res,1993,34:421
  • 5Gambino R,Scaglione L,Alemanno N,et al. Human lipoprotein lipase HindⅢ polymorphism in young patients with myocardial infarction. Metabolism,1999,48(9),1 157
  • 6康格非主编.临床生物化学和生物化学检验.第二版. 北京:人民卫生出版社,1998,70-73
  • 7张秋萍,刘秉文,刘宇,张蓉,张荣爵,江渝,付明德,吴兆丰,David J.Galton.中国人内源性高甘油三酯血症患者脂蛋白脂酶及肝脂酶常见基因变异的研究[J].中华医学遗传学杂志,1997,14(5):289-293. 被引量:19
  • 8朱铁兵,杨志健,王强,孔祥清,马根山,杨斌,王震震,张馥敏,曹克将,马文珠.脂蛋白脂酸基因多态性与冠状动脉病变严重度的关系[J].江苏医药,1998,24(4):250-251. 被引量:1

共引文献6

同被引文献60

引证文献8

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部